NeuroScienceLab Essen
Dr. med. Michael Fleischer

Clinician scientist
Office: MFZ, 2nd floor, room 2.016
Phone: +49 201 723 83181
Fax: +49 201 723 6903

Michael Fleischer studied medicine at the University Leipzig, where he graduated 2012. His doctoral thesis focused on the genetic characterization of glucose metabolism in high-grade glioma analysing PFKB2 isoforms in the group of Prof. K. Eschrich. Besides, he studied fatigue in patients with sarcoidosis in the group of Prof. E. Brähler under the supervision of Prof. A. Hinz. After graduation, Michael Fleischer started his residency in clinical neurology at the University Hospital Würzburg with Prof. J. Volkmann. Apart from clinics, he was involved into electrophysiological studies at the Institute for Clinical Neurobiology, where he established an electrophysiological patch-clamp setup and performed near infrared laser studies of human embryonic kidney cells and dorsal root ganglion neurons. In collaboration with Prof. H. Endres of School of Applied Science Würzburg-Schweinfurt, he developed an implantable stimulator for the exploration of deep brain stimulation in mice. He joined the NeuroScienceLab in 2017.
Research interests

Michael Fleischer is interested in molecular and system biological processes that control neuronal plasticity and synapse formation in neurological diseases with a focus on stroke. Furthermore, he characterizes functional effects of chemotherapeutics in single neuron preparations.
Key publications

Fleischer M, Kessler R, Klammer A, Warnke JP, Eschrich K. LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas. Genes Chrom Cancer. 2011; 50:1010-20.

Hinz A, Fleischer M, Brähler E, Wirtz H, Bosse-Henck A. Fatigue in patients with sarcoidosis, compared with the general population. Gen Hosp Psychiatry. 2011; 33:462-8.

Fleischer M, Hinz A, Brähler E, Wirtz H, Bosse-Henck A. Predictors of fatigue in patients with sarcoidosis. Respir Care. 2014; 59:1086-94.

Fluri F, Fleischer M, Kleinschnitz C. Accidental thrombolysis in a stroke patient receiving apixaban. Cerebrovasc Dis Extra. 2015; 5:55-6.
NeuroScienceLab Sekretariat